Role of reactive oxygen species in the regulation of cardiac contractility

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 5, 2011, Pages 884-893

  Kubin, Anna Maria ^a   Skoumal, Réka ^a,d   Tavi, Pasi ^b   Kónyi, Attila ^c   Perjés, Ábel ^c   Leskinen, Hanna ^a   Ruskoaho, Heikki ^a   Szokodi, István ^c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF PHYSICAL EDUCATION   (Hungary)

Author keywords

Contractility; Endothelin 1; Reactive oxygen species; Receptor, adrenergic, beta; Signal transduction

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLAMBAN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; MOLECULAR DYNAMICS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; ENDOTHELIN-1; ETHIDIUM; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL CONTRACTION; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 79953700537     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.02.005     Document Type: Article

References (64)

1. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508.
2. Sawyer D.B., Siwik D.A., Xiao L., Pimentel D.R., Singh K., Colucci W.S. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002, 34:379-388.
3. Zimmet J.M., Hare J.M. Nitroso-redox interactions in the cardiovascular system. Circulation 2006, 114:1531-1544.
4. Murdoch C.E., Zhang M., Cave A.C., Shah A.M. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 2006, 71:208-215.
5. Zima A.V., Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006, 71:310-321.
6. Heinzel F.R., Luo Y., Dodoni G., Boengler K., Petrat F., Di Lisa F., et al. Formation of reactive oxygen species at increased contraction frequency in rat cardiomyocytes. Cardiovasc Res 2006, 71:374-382.
7. Saitoh S., Zhang C., Tune J.D., Potter B., Kiyooka T., Rogers P.A., et al. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol 2006, 26:2614-2621.
8. Wenzel S., Tastan I., Abdallah Y., Schreckenberg R., Schluter K.D. Aldosterone improves contractile function of adult rat ventricular cardiomyocytes in a non-acute way: potential relationship to the calcium paradox of aldosteronism. Basic Res Cardiol 2010, 105:247-256.
9. Mak S., Newton G.E. Vitamin C augments the inotropic response to dobutamine in humans with normal left ventricular function. Circulation 2001, 103:826-830.
10. Dong F., Zhang X., Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension 2006, 47:222-229.
11. Sand C., Peters S.L., Pfaffendorf M., Van Zwieten P.A. The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulation. Naunyn Schmiedebergs Arch Pharmacol 2003, 367:635-639.
12. Cingolani H.E., Villa-Abrille M.C., Cornelli M., Nolly A., Ennis I.L., Garciarena C., et al. The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species. Hypertension 2006, 47:727-734.
13. De Giusti V.C., Correa M.V., Villa-Abrille M.C., Beltrano C., Yeves A.M., de Cingolani G.E., et al. The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species. Life Sci 2008, 83:264-271.
14. Sugden P.H. An overview of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol 2003, 35:871-886.
15. Endoh M. Signal transduction and Ca2+ signaling in intact myocardium. J Pharmacol Sci 2006, 100:525-537.
16. Takeuchi Y., Kihara Y., Inagaki K., Yoneda T., Sasayama S. Endothelin-1 has a unique oxygen-saving effect by increasing contractile efficiency in the isolated rat heart. Circulation 2001, 103:1557-1563.
17. Piuhola J., Makinen M., Szokodi I., Ruskoaho H. Dual role of endothelin-1 via ETA and ETB receptors in regulation of cardiac contractile function in mice. Am J Physiol Heart Circ Physiol 2003, 285:H112-H118.
18. Dzimiri N. Regulation of beta-adrenoceptor signaling in cardiac function and disease. Pharmacol Rev 1999, 51:465-501.
19. Szokodi I., Kerkela R., Kubin A.M., Sarman B., Pikkarainen S., Konyi A., et al. Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility. Circulation 2008, 118:1651-1658.
20. Piuhola J., Szokodi I., Kinnunen P., Ilves M., deChatel R., Vuolteenaho O., et al. Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts. Hypertension 2003, 41:93-98.
21. Szokodi I., Kinnunen P., Tavi P., Weckstrom M., Toth M., Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 1998, 97:1062-1070.
22. Cheng T.H., Shih N.L., Chen S.Y., Wang D.L., Chen J.J. Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 1999, 41:654-662.
23. Amin J.K., Xiao L., Pimental D.R., Pagano P.J., Singh K., Sawyer D.B., et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 2001, 33:131-139.
24. Pain T., Yang X.M., Critz S.D., Yue Y., Nakano A., Liu G.S., et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000, 87:460-466.
25. Gok S., Vural K., Sekuri C., Onur R., Tezcan A., Izanli A. Effects of the blockade of cardiac sarcolemmal ATP-sensitive potassium channels on arrhythmias and coronary flow in ischemia-reperfusion model in isolated rat hearts. Vascul Pharmacol 2006, 44:197-205.
26. Cao C.M., Xia Q., Gao Q., Chen M., Wong T.M. Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning. J Pharmacol Exp Ther 2005, 312:644-650.
27. Sovershaev M.A., Egorina E.M., Andreasen T.V., Jonassen A.K., Ytrehus K. Preconditioning by 17beta-estradiol in isolated rat heart depends on PI3-K/PKB pathway, PKC, and ROS. Am J Physiol Heart Circ Physiol 2006, 291:H1554-H1562.
28. Kevin L.G., Camara A.K., Riess M.L., Novalija E., Stowe D.F. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2003, 284:H566-H574.
29. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000, 86:494-501.
30. Yang H.Y., Liu J.C., Chen Y.L., Chen C.H., Lin H., Lin J.W., et al. Inhibitory effect of trilinolein on endothelin-1-induced c-fos gene expression in cultured neonatal rat cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 2005, 372:160-167.
31. Forbes R.A., Steenbergen C., Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 2001, 88:802-809.
32. Heinzel F.R., Luo Y., Li X., Boengler K., Buechert A., Garcia-Dorado D., et al. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 2005, 97:583-586.
33. Tanaka K., Honda M., Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 2001, 37:676-685.
34. Clerk A., Sugden P.H. Ras: the stress and the strain. J Mol Cell Cardiol 2006, 41:595-600.
35. Luo W., Grupp I.L., Harrer J., Ponniah S., Grupp G., Duffy J.J., et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 1994, 75:401-409.
36. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003, 4:566-577.
37. Bolli R., Jeroudi M.O., Patel B.S., DuBose C.M., Lai E.K., Roberts R., et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci U S A 1989, 86:4695-4699.
38. Perez N.G., Gao W.D., Marban E. Novel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitors. Circ Res 1998, 83:423-430.
39. Asimakis G.K., Lick S., Patterson C. Postischemic recovery of contractile function is impaired in SOD2(+/-) but not SOD1(+/-) mouse hearts. Circulation 2002, 105:981-986.
40. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A., Murphy M.P., et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005, 19:1088-1095.
41. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008, 88:581-609.
42. Di Lisa F., Kaludercic N., Carpi A., Menabo R., Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res Cardiol 2009, 104:131-139.
43. Saavedra W.F., Paolocci N., St.John M.E., Skaf M.W., Stewart G.C., Xie J.S., et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 2002, 90:297-304.
44. Grieve D.J., Byrne J.A., Siva A., Layland J., Johar S., Cave A.C., et al. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol 2006, 47:817-826.
45. Hunlich M., Hasenfuss G. Effects of the NO donor sodium nitroprusside on oxygen consumption and energetics in rabbit myocardium. Basic Res Cardiol 2009, 104:359-365.
46. Shiva S., Gladwin M.T. Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res Cardiol 2009, 104:113-119.
47. Steenbergen C., Das S., Su J., Wong R., Murphy E. Cardioprotection and altered mitochondrial adenine nucleotide transport. Basic Res Cardiol 2009, 104:149-156.
48. Chen W., Gabel S., Steenbergen C., Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 1995, 77:424-429.
49. Heusch G., Boengler K., Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919.
50. Akki A., Zhang M., Murdoch C., Brewer A., Shah A.M. NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 2009, 47:15-22.
51. Brunner F., Bras-Silva C., Cerdeira A.S., Leite-Moreira A.F. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006, 111:508-531.
52. Nishimaru K., Arimoto T., Takeishi Y., Kubota I., Ishii K., Endoh M. Overexpression of diacylglycerol kinase zeta inhibits endothelin-1-induced decreases in Ca2+ transients and cell shortening in mouse ventricular myocytes. J Mol Cell Cardiol 2008, 44:520-526.
53. Garlid K.D., Puddu P.E., Pasdois P., Costa A.D., Beauvoit B., Criniti A., et al. Inhibition of cardiac contractility by 5-hydroxydecanoate and tetraphenylphosphonium ion: a possible role of mitoKATP in response to inotropic stress. Am J Physiol Heart Circ Physiol 2006, 291:H152-H160.
54. Wetzker R., Bohmer F.D. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 2003, 4:651-657.
55. Chu L., Takahashi R., Norota I., Miyamoto T., Takeishi Y., Ishii K., et al. Signal transduction and Ca2+ signaling in contractile regulation induced by crosstalk between endothelin-1 and norepinephrine in dog ventricular myocardium. Circ Res 2003, 92:1024-1032.
56. Bogoyevitch M.A., Glennon P.E., Andersson M.B., Clerk A., Lazou A., Marshall C.J., et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 1994, 269:1110-1119.
57. Pimentel D.R., Adachi T., Ido Y., Heibeck T., Jiang B., Lee Y., et al. Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol 2006, 41:613-622.
58. Li S., Li X., Zheng H., Xie B., Bidasee K.R., Rozanski G.J. Pro-oxidant effect of transforming growth factor- beta1 mediates contractile dysfunction in rat ventricular myocytes. Cardiovasc Res 2008, 77:107-117.
59. Grill H.P., Zweier J.L., Kuppusamy P., Weisfeldt M.L., Flaherty J.T. Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J Am Coll Cardiol 1992, 20:1604-1611.
60. Faulkner K.M., Liochev S.I., Fridovich I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J Biol Chem 1994, 269:23471-23476.
61. Heumuller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schroder K., et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51:211-217.
62. Touyz R.M. Apocynin, NADPH oxidase, and vascular cells: a complex matter. Hypertension 2008, 51:172-174.
63. Liu H.R., Tao L., Gao E., Qu Y., Lau W.B., Lopez B.L., et al. Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation-a novel mechanism for the cardioprotective effects of PPAR agonists. Cardiovasc Res 2009, 81:344-352.
64. De Giusti V.C., Garciarena C.D., Aiello E.A. Role of reactive oxygen species (ROS) in angiotensin II-induced stimulation of the cardiac Na+/HCO3- cotransport. J Mol Cell Cardiol 2009, 47:716-722.